iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership27,200 shares
Latest Disclosed Value $ 4,592,806
Private Advisor Group, LLC reports 3.03% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 27,200 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $4,592,806 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 26,400 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 3.03% during the quarter. The current value of the position is $3,564,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 27,200 800 3.03 4,593 3.08 0.0204
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 26,400 -4,340 -14.12 4,455 0.41 0.0201
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 30,740 6,160 25.06 4,438 42.71 0.0218
2025-08-11 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 24,580 -2,981 -10.82 3,110 -11.80 0.0167
2025-05-05 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 27,561 -1,234 -4.29 3,525 -7.38 0.0213
2025-02-03 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 28,795 -3,299 -10.28 3,807 -18.54 0.0214
2024-10-22 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 32,094 -1,213 -3.64 4,673 2.19 0.0290
2024-08-05 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 33,307 -4,929 -12.89 4,573 -12.83 0.0307
2024-04-30 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 38,236 -5,753 -13.08 5,245 -12.22 0.0377
2024-02-06 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 43,989 -6,668 -13.16 5,975 -3.21 0.0464
2023-11-03 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 50,657 2,294 4.74 6,174 0.21 0.0552
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 48,363 1,683 3.61 6,160 2.17 0.0535
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 46,680 -545 -1.15 6,029 805.26 0.0576
2023-01-18 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 47,225 6,895 17.10 667 -85.88 0.0336
2022-10-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 40,330 -2,179 -5.13 4,717 -5.66 0.0542
2022-07-13 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 42,509 -2,054 -4.61 5,000 -13.90 0.0446
2022-05-12 2022-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 44,563 -2,684 -5.68 5,807 -19.47 0.0445
2022-05-10 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 47,247 0 7,211 0.0542
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 47,247 1,360 2.96 7,211 -2.80 0.0541
2021-10-14 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 45,887 6,660 16.98 7,419 15.58 0.0472
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 39,227 -160 -0.41 6,419 8.25 0.0561
2021-04-22 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 39,387 499 1.28 5,930 0.66 0.0566
2021-04-01 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 38,888 -27,300 -41.25 5,891 -34.54 0.0614
2020-11-02 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 66,188 2,487 3.90 9,000 3.37 0.1170
2020-08-17 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 63,701 18,224 40.07 8,707 77.69 0.1209
2020-05-12 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45,477 9,411 26.09 4,900 12.75 0.0899
2020-02-10 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 36,066 -54,463 -60.16 4,346 -51.75 0.0676
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 90,529 -3,534 -3.76 9,008 -12.22 0.1401
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 94,063 -7,909 -7.76 10,262 -9.99 0.1855
2019-05-13 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 101,972 11,554 12.78 11,401 30.76 0.2250
2019-02-08 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 90,418 51,001 129.39 8,719 81.38 0.2102
2018-11-01 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 39,417 23,885 153.78 4,807 179.80 0.0985
2018-08-09 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 15,532 -17,099 -52.40 1,718 -50.67 0.0282
2018-05-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 32,631 12,410 61.37 3,483 59.11 0.1363
2018-02-07 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 20,221 1,798 9.76 2,189 -64.98 0.0925
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 18,423 -2,388 -11.47 6,251 -3.09 0.1546
2017-08-10 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 20,811 7,441 55.65 6,450 67.79 0.1745
2017-05-10 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 13,370 -4,640 -25.76 3,844 -23.21 0.1075
2017-02-09 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 18,010 4,671 35.02 5,006 30.20 0.1641
2016-11-10 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 13,339 3,836 40.37 3,845 51.98 0.1568
2016-08-09 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 9,503 742 8.47 2,530 10.72 0.1022
2016-05-13 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 8,761 -4,995 -36.31 2,285 -50.90 0.1104
2016-02-09 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 13,756 4,966 56.50 4,654 74.57 0.2232
2015-11-13 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 8,790 1,667 23.40 2,666 1.45 0.1466
2015-08-13 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 7,123 1,696 31.25 2,628 40.99 0.1247
2015-05-13 2015-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 5,427 1,323 32.24 1,864 49.72 0.1074
2015-02-17 2014-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 4,104 -117 -2.77 1,245 7.79 0.0802
2014-11-12 2014-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 4,221 -1,564 -27.04 1,155 -22.33 0.0799
2014-08-08 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 5,785 -1,236 -17.60 1,487 -10.42 0.1279
2014-05-15 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 7,021 -26 -0.37 1,660 3.75 0.1750
2014-02-13 2013-12-31 13F ISHARES NASDQ BIOTEC ETF 464287556 7,047 7,047 1,600 0.1787
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.